Atenolol
NDC Package 21695-322-30

11-digit billing NDC: 21695032230 · Billing unit: EA · 30 EA per package

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Atenolol is iNDICATIONS AND USAGEHypertensionAtenolol is indicated in the management of hypertension. Marketed by Rebel Distributors Corp., this product is identified by NDC 21695-322 and is authorized under FDA application ANDA077877.

Identification & Billing

NDC Package Code
21695-322-30
Package Description
30 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
21695032230
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk
RxCUI: 197380 - atenolol 25 MG Oral Tablet

Clinical Specifications

Proprietary Name
Atenolol
Dosage Form
-
Usage Information
INDICATIONS AND USAGEHypertensionAtenolol is indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.Angina Pectoris Due to Coronary AtherosclerosisAtenolol is indicated for the long-term management of patients with angina pectoris.Acute Myocardial InfarctionAtenolol is indicated in the management of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. Treatment can be initiated as soon as the patient’s clinical condition allows (see DOSAGE AND ADMINISTRATION, CONTRAINDICATIONS, and WARNINGS). In general, there is no basis for treating patients like those who were excluded from the ISIS-1 trial (blood pressure less than 100 mm Hg systolic, heart rate less than 50 bpm) or have other reasons to avoid beta-blockade. As noted above, some subgroups (e.g., elderly patients with systolic blood pressure below 120 mm Hg) seemed less likely to benefit.

Regulatory & Marketing

Labeler Name
Rebel Distributors Corp.
FDA Application #
ANDA077877
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-19-1995
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (21695-322). Click a package code to view its specific billing and regulatory data.

90 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 21695-322-30 identifies a specific commercial package of 30 tablet in 1 bottle of Atenolol, labeled by Rebel Distributors Corp.. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rebel Distributors Corp. on July 19, 1995. The current certification is valid through December 31, 2017.

How is this Rebel Distributors Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 21695032230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
21695-322-30
11-Digit CMS (5-4-2)
21695-0322-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.